The PP2A-B56 Phosphatase Opposes Cyclin E Autocatalytic Degradation via Site-Specific Dephosphorylation

REFERENCES

• Siu KT, Rosner MR, Minella AC. 2012. An integrated view of cyclin E function and regulation. Cell Cycle 11:57–64. https://doi.org/10.4161/cc.11.1.18775.
   PubMed Web of Science ®Google Scholar
• Hwang HC, Clurman BE. 2005. Cyclin E in normal and neoplastic cell cycles. Oncogene 24:2776–2786. https://doi.org/10.1038/sj.onc.1208613.
   PubMed Web of Science ®Google Scholar
• Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, Clurman BE. 2008. Identification of CDK2 substrates in human cell lysates. Genome Biol 9:R149. https://doi.org/10.1186/gb-2008-9-10-r149.
   PubMedGoogle Scholar
• Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P. 2007. Kinase-independent function of cyclin E. Mol Cell 25:127–139. https://doi.org/10.1016/j.molcel.2006.11.029.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Maller JL. 2004. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 306:885–888. https://doi.org/10.1126/science.1103544.
   PubMed Web of Science ®Google Scholar
• Spruck CH, Won KA, Reed SI. 1999. Deregulated cyclin E induces chromosome instability. Nature 401:297–300. https://doi.org/10.1038/45836.
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Roberts JM. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908–1912. https://doi.org/10.1126/science.8384376.
   PubMed Web of Science ®Google Scholar
• Minella AC, Grim JE, Welcker M, Clurman BE. 2007. p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26:6948–6953. https://doi.org/10.1038/sj.onc.1210518.
   PubMedGoogle Scholar
• Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B. 2011. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145:435–446. https://doi.org/10.1016/j.cell.2011.03.044.
   PubMed Web of Science ®Google Scholar
• Costantino L, Sotiriou SK, Rantala JK, Magin S, Mladenov E, Helleday T, Haber JE, Iliakis G, Kallioniemi OP, Halazonetis TD. 2014. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343:88–91. https://doi.org/10.1126/science.1243211.
   PubMed Web of Science ®Google Scholar
• Keck JM, Summers MK, Tedesco D, Ekholm-Reed S, Chuang LC, Jackson PK, Reed SI. 2007. Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1). J Cell Biol 178:371–385. https://doi.org/10.1083/jcb.200703202.
   PubMed Web of Science ®Google Scholar
• Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. 2002. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr Biol 12:1817–1827. https://doi.org/10.1016/S0960-9822(02)01225-3.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490:61–70. https://doi.org/10.1038/nature11412.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474:609–615. https://doi.org/10.1038/nature10166.
   PubMed Web of Science ®Google Scholar
• Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya DK, Clurman BE, Roberts JM. 2005. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8:35–47. https://doi.org/10.1016/j.ccr.2005.06.010.
   PubMedGoogle Scholar
• Smith AP, Henze M, Lee JA, Osborn KG, Keck JM, Tedesco D, Bortner DM, Rosenberg MP, Reed SI. 2006. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland. Oncogene 25:7245–7259. https://doi.org/10.1038/sj.onc.1209713.
   PubMed Web of Science ®Google Scholar
• Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ. 2001. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294:173–177. https://doi.org/10.1126/science.1065203.
   PubMed Web of Science ®Google Scholar
• Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. 2001. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322. https://doi.org/10.1038/35095076.
   PubMed Web of Science ®Google Scholar
• Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10:1979–1990. https://doi.org/10.1101/gad.10.16.1979.
   PubMed Web of Science ®Google Scholar
• Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, Clurman BE, Roberts JM. 2003. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 12:381–392. https://doi.org/10.1016/S1097-2765(03)00287-9.
   PubMed Web of Science ®Google Scholar
• Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. 2001. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413:311–316. https://doi.org/10.1038/35095068.
   PubMed Web of Science ®Google Scholar
• Won KA, Reed SI. 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E EMBO J15:4182–4193.
   Google Scholar
• Nash P, Tang X, Orlicky S, Chen Q, Gertler FB, Mendenhall MD, Sicheri F, Pawson T, Tyers M. 2001. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414:514–521. https://doi.org/10.1038/35107009.
   PubMed Web of Science ®Google Scholar
• Davis RJ, Welcker M, Clurman BE. 2014. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. Cancer Cell 26:455–464. https://doi.org/10.1016/j.ccell.2014.09.013.
   PubMed Web of Science ®Google Scholar
• Siu KT, Xu Y, Swartz KL, Bhattacharyya M, Gurbuxani S, Hua Y, Minella AC. 2014. Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation. Mol Cell Biol 34:3244–3258. https://doi.org/10.1128/MCB.01528-13.
   PubMedGoogle Scholar
• Xu Y, Swartz KL, Siu KT, Bhattacharyya M, Minella AC. 2014. Fbw7-dependent cyclin E regulation ensures terminal maturation of bone marrow erythroid cells by restraining oxidative metabolism. Oncogene 33:3161–3171. https://doi.org/10.1038/onc.2013.289.
   PubMedGoogle Scholar
• Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, Hwang HC, Ericsson J, Russell DW, Clurman BE. 2008. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 181:913–920. https://doi.org/10.1083/jcb.200802076.
   PubMed Web of Science ®Google Scholar
• Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M, Zetterberg A, Reed SI, Reed SE. 2004. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 64:795–800. https://doi.org/10.1158/0008-5472.CAN-03-3417.
   PubMedGoogle Scholar
• Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, Roberts JM, Clurman BE. 2008. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 22:1677–1689. https://doi.org/10.1101/gad.1650208.
   PubMedGoogle Scholar
• Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. 2007. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 26:131–143. https://doi.org/10.1016/j.molcel.2007.02.022.
   PubMed Web of Science ®Google Scholar
• Arnold HK, Sears RC. 2006. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 26:2832–2844. https://doi.org/10.1128/MCB.26.7.2832-2844.2006.
   PubMed Web of Science ®Google Scholar
• Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. 2004. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308–318. https://doi.org/10.1038/ncb1110.
   PubMed Web of Science ®Google Scholar
• McCourt P, Gallo-Ebert C, Gonghong Y, Jiang Y, Nickels JT. 2013. PP2A(Cdc55) regulates G1 cyclin stability. Cell Cycle 12:1201–1210. https://doi.org/10.4161/cc.24231.
   PubMed Web of Science ®Google Scholar
• Shi Y. 2009. Serine/threonine phosphatases: mechanism through structure. Cell 139:468–484. https://doi.org/10.1016/j.cell.2009.10.006.
   PubMed Web of Science ®Google Scholar
• Wlodarchak N, Xing Y. 2016. PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol 51:162–184. https://doi.org/10.3109/10409238.2016.1143913.
   PubMed Web of Science ®Google Scholar
• Wurzenberger C, Gerlich DW. 2011. Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol 12:469–482. https://doi.org/10.1038/nrm3149.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen Y, Zhang P, Jeffrey PD, Shi Y. 2008. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol Cell 31:873–885. https://doi.org/10.1016/j.molcel.2008.08.006.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xing Y, Chen Y, Chao Y, Lin Z, Fan E, Yu JW, Strack S, Jeffrey PD, Shi Y. 2006. Structure of the protein phosphatase 2A holoenzyme. Cell 127:1239–1251. https://doi.org/10.1016/j.cell.2006.11.033.
   PubMed Web of Science ®Google Scholar
• Swingle M, Ni L, Honkanen RE. 2007. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol Biol 365:23–38.
   PubMedGoogle Scholar
• Mitsuhashi S, Matsuura N, Ubukata M, Oikawa H, Shima H, Kikuchi K. 2001. Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Biochem Biophys Res Commun 287:328–331. https://doi.org/10.1006/bbrc.2001.5596.
   PubMed Web of Science ®Google Scholar
• Foley EA, Maldonado M, Kapoor TM. 2011. Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase. Nat Cell Biol 13:1265–1271. https://doi.org/10.1038/ncb2327.
   PubMed Web of Science ®Google Scholar
• Espert A, Uluocak P, Bastos RN, Mangat D, Graab P, Gruneberg U. 2014. PP2A-B56 opposes Mps1 phosphorylation of Knl1 and thereby promotes spindle assembly checkpoint silencing. J Cell Biol 206:833–842. https://doi.org/10.1083/jcb.201406109.
   PubMedGoogle Scholar
• Xu P, Raetz EA, Kitagawa M, Virshup DM, Lee SH. 2013. BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression. Biol Open 2:479–486. https://doi.org/10.1242/bio.20134051.
   PubMed Web of Science ®Google Scholar
• Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, Goris J, Trinkle-Mulcahy L, Lamond AI, Poser I, Hyman AA, Mechtler K, Peters JM, Gerlich DW. 2010. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 12:886–893. https://doi.org/10.1038/ncb2092.
   PubMed Web of Science ®Google Scholar
• Cundell MJ, Bastos RN, Zhang T, Holder J, Gruneberg U, Novak B, Barr FA. 2013. The BEG (PP2A-B55/ENSA/Greatwall) pathway ensures cytokinesis follows chromosome separation. Mol Cell 52:393–405. https://doi.org/10.1016/j.molcel.2013.09.005.
   PubMedGoogle Scholar
• Grallert A, Boke E, Hagting A, Hodgson B, Connolly Y, Griffiths JR, Smith DL, Pines J, Hagan IM. 2015. A PP1-PP2A phosphatase relay controls mitotic progression. Nature 517:94–98.
   PubMed Web of Science ®Google Scholar
• Porter IM, Schleicher K, Porter M, Swedlow JR. 2013. Bod1 regulates protein phosphatase 2A at mitotic kinetochores. Nat Commun 4:2677.
   PubMedGoogle Scholar
• Tan Y, Sun D, Jiang W, Klotz-Noack K, Vashisht AA, Wohlschlegel J, Widschwendter M, Spruck C. 2014. PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer. Cancer Res 74:2006–2014. https://doi.org/10.1158/0008-5472.CAN-13-1263.
   PubMedGoogle Scholar
• Tan J, Lee PL, Li Z, Jiang X, Lim YC, Hooi SC, Yu Q. 2010. B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 18:459–471. https://doi.org/10.1016/j.ccr.2010.10.021.
   PubMed Web of Science ®Google Scholar
• Mayr D, Kanitz V, Anderegg B, Luthardt B, Engel J, Löhrs U, Amann G, Diebold J. 2006. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays. Am J Clin Pathol 126:101–109. https://doi.org/10.1309/N6X5MB24BP42KP20.
   PubMedGoogle Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. 2012. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1.
   PubMed Web of Science ®Google Scholar
• Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW. 2008. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283:1882–1892. https://doi.org/10.1074/jbc.M709585200.
   PubMed Web of Science ®Google Scholar
• Rundell K, Parakati R. 2001. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 11:5–13. https://doi.org/10.1006/scbi.2000.0341.
   PubMed Web of Science ®Google Scholar
• Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167–176.
   PubMed Web of Science ®Google Scholar
• Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M. 2000. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 19:1191–1195. https://doi.org/10.1038/sj.onc.1203389.
   PubMed Web of Science ®Google Scholar
• Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA. 1998. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282:284–287.
   PubMed Web of Science ®Google Scholar
• Chen W, Arroyo JD, Timmons JC, Possemato R, Hahn WC. 2005. Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity. Cancer Res 65:8183–8192. https://doi.org/10.1158/0008-5472.CAN-05-1103.
   PubMed Web of Science ®Google Scholar
• Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, Elledge SJ, Clurman BE, Harper JW. 2004. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 279:50110–50119. https://doi.org/10.1074/jbc.M409226200.
   PubMed Web of Science ®Google Scholar
• Graham FL, van der Eb AJ. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Hughes BT, Sidorova J, Swanger J, Monnat RJ, Clurman BE. 2013. Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation. Proc Natl Acad Sci U S A 110:8954–8959. https://doi.org/10.1073/pnas.1302927110.
   PubMed Web of Science ®Google Scholar